Evaluation of the Test Temperature Effect on Failure Mechanisms and Notched Impact Strength Characteristics of Ultra-Hard Low Alloy Steels

На основании данных фрактографического анализа оценено изменение механизмов разрушения высокопрочных малолегированных сталей ARMOX 500T и ARMOX 600T в зависимости оттемпературы испытаний. В экспериментально исследованномтемпературном диапазоне -80...100°C была установлена высокая вероятность достижения предельного состояния этих материалов.На основі даних фрактографічного аналізу оцінено зміну механізмів руйнування високоміцних малолегованих сталейARMOX 500T та ARMOX 600T у залежності від температури випробувань. В експериментально дослідженому температурному інтервалі-80...100°C установлено високу імовірність досягнення граничного стану цих матеріалів

Characterization of SNF 9007, A Novel Cholecystokinin/Opoid Ligand in Mouse Ileum in Vitro: Evidence for Involvement of CholecystokininA and CholecystokininB Receptors in Regulation of Ion Transport1

ABSTRACT The effects of cholecystokinin (CCK) fragments and Asp-Tyr-DPh Gly-Trp-[N-Me]Nle-Asp-Phe-NH

Electron-wall interaction in Hall thrusters

Electron-wall interaction effects in Hall thrusters are studied through measurements of the plasma response to variations of the thruster channel width and the discharge voltage. The discharge voltage threshold is shown to separate two thruster regimes. Below this threshold, the electron energy gain is constant in the acceleration region and therefore, secondary electron emission (SEE) from the channel walls is insufficient to enhance electron energy losses at the channel walls. Above this voltage threshold, the maximum electron temperature saturates. This result seemingly agrees with predictions of the temperature saturation, which recent Hall thruster models explain as a transition to space-charge saturated regime of the near-wall sheath. However, in the experiment, the maximum saturation temperature exceeds by almost three times the critical value estimated under the assumption of a Maxwellian electron energy distribution function. The channel narrowing, which should also enhance electron-wall collisions, causes unexpectedly larger changes of the plasma potential distribution than does the increase of the electron temperature with the discharge voltage. An enhanced anomalous crossed-field mobility (near wall or Bohm-type) is suggested by a hydrodynamic model as an explanation to the reduced electric field measured inside a narrow channel. We found, however, no experimental evidence of a coupling between the maximum electron temperature and the location of the accelerating voltage drop, which might have been expected due to the SEE-induced near-wall conductivity.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/87763/2/057104_1.pd

Homogeneous Bubble Nucleation driven by local hot spots: a Molecular Dynamics Study

We report a Molecular Dynamics study of homogenous bubble nucleation in a Lennard-Jones fluid. The rate of bubble nucleation is estimated using forward-flux sampling (FFS). We find that cavitation starts with compact bubbles rather than with ramified structures as had been suggested by Shen and Debenedetti (J. Chem. Phys. 111:3581, 1999). Our estimate of the bubble-nucleation rate is higher than predicted on the basis of Classical Nucleation Theory (CNT). Our simulations show that local temperature fluctuations correlate strongly with subsequent bubble formation - this mechanism is not taken into account in CNT

Real-Time Image Guided Ablative Prostate Cancer Radiation Therapy: Results From the TROG 15.01 SPARK Trial.

PurposeKilovoltage intrafraction monitoring (KIM) is a novel software platform implemented on standard radiation therapy systems and enabling real-time image guided radiation therapy (IGRT). In a multi-institutional prospective trial, we investigated whether real-time IGRT improved the accuracy of the dose patients with prostate cancer received during radiation therapy.Methods and materialsForty-eight patients with prostate cancer were treated with KIM-guided SABR with 36.25 Gy in 5 fractions. During KIM-guided treatment, the prostate motion was corrected for by either beam gating with couch shifts or multileaf collimator tracking. A dose reconstruction method was used to evaluate the dose delivered to the target and organs at risk with and without real-time IGRT. Primary outcome was the effect of real-time IGRT on dose distributions. Secondary outcomes included patient-reported outcomes and toxicity.ResultsMotion correction occurred in ≥1 treatment for 88% of patients (42 of 48) and 51% of treatments (121 of 235). With real-time IGRT, no treatments had prostate clinical target volume (CTV) D98% dose 5% less than planned. Without real-time IGRT, 13 treatments (5.5%) had prostate CTV D98% doses 5% less than planned. The prostate CTV D98% dose with real-time IGRT was closer to the plan by an average of 1.0% (range, -2.8% to 20.3%). Patient outcomes showed no change in the 12-month patient-reported outcomes compared with baseline and no grade ≥3 genitourinary or gastrointestinal toxicities.ConclusionsReal-time IGRT is clinically effective for prostate cancer SABR

Electromagnetic-Guided MLC Tracking Radiation Therapy for Prostate Cancer Patients: Prospective Clinical Trial Results.

PURPOSE: To report on the primary and secondary outcomes of a prospective clinical trial of electromagnetic-guided multileaf collimator (MLC) tracking radiation therapy for prostate cancer. METHODS AND MATERIALS: Twenty-eight men with prostate cancer were treated with electromagnetic-guided MLC tracking with volumetric modulated arc therapy. A total of 858 fractions were delivered, with the dose per fraction ranging from 2 to 13.75 Gy. The primary outcome was feasibility, with success determined if >95% of fractions were successfully delivered. The secondary outcomes were (1) the improvement in beam-target geometric alignment, (2) the improvement in dosimetric coverage of the prostate and avoidance of critical structures, and (3) no acute grade ≥3 genitourinary or gastrointestinal toxicity. RESULTS: All 858 planned fractions were successfully delivered with MLC tracking, demonstrating the primary outcome of feasibility (P < .001). MLC tracking improved the beam-target geometric alignment from 1.4 to 0.90 mm (root-mean-square error). MLC tracking improved the dosimetric coverage of the prostate and reduced the daily variation in dose to critical structures. No acute grade ≥3 genitourinary or gastrointestinal toxicity was observed. CONCLUSIONS: Electromagnetic-guided MLC tracking radiation therapy for prostate cancer is feasible. The patients received improved geometric targeting and delivered dose distributions that were closer to those planned than they would have received without electromagnetic-guided MLC tracking. No significant acute toxicity was observed

Dairy consumption and cardiometabolic diseases: systematic review and updated meta-analyses of prospective cohort studies

Purpose of Review Dairy products contain both beneficial and harmful nutrients in relation to cardiometabolic diseases. Here, we provide the latest scientific evidence regarding the relationship between dairy products and cardiometabolic diseases by reviewing the literature and updating meta-analyses of observational studies. Recent Findings We updated our previous meta-analyses of cohort studies on type 2 diabetes, coronary heart disease (CHD), and stroke with nine studies and confirmed previous results. Total dairy and low-fat dairy (per 200 g/d) were inversely associated with a 3–4% lower risk of diabetes. Yogurt was non-linearly inversely associatedwith diabetes (RR = 0.86, 95%CI: 0.83–0.90 at 80 g/ d). Total dairy and milk were not associated with CHD (RR~1.0). An increment of 200 g of daily milk intake was associated with an 8% lower risk of stroke. Summary The latest scientific evidence confirmed neutral or beneficial associations between dairy products and risk of cardiometabolic diseases